'Stealth' corporate innovation: an emerging threat for therapeutic drug development

Mastellos, Dimitrios C., Blom, Anna M., Connolly, E. Sander, Daha, Mohamed R., Geisbrecht, Brian V., Ghebrehiwet, Berhane, Gros, Piet, Hajishengallis, George, Holers, V. Michael, Huber-Lang, Markus, Kinoshita, Taroh, Mollnes, Tom E., Montgomery, Robert A., Morgan, B. Paul ORCID: https://orcid.org/0000-0003-4075-7676, Nilsson, Bo, Pio, Ruben, Ricklin, Daniel, Risitano, Antonio M., Taylor, Ronald P., Mantovani, Alberto, Ioannidis, John P. A. and Lambris, John D. 2019. 'Stealth' corporate innovation: an emerging threat for therapeutic drug development. Nature Immunology 20 (11) , pp. 1409-1413. 10.1038/s41590-019-0503-1

Preview

PDF - Accepted Post-Print Version Download (314kB) | Preview

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Nature Publishing Group
ISSN:	1529-2908
Date of First Compliant Deposit:	16 December 2019
Date of Acceptance:	20 August 2019
Last Modified:	30 Nov 2024 16:30
URI:	https://orca.cardiff.ac.uk/id/eprint/127575

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item